Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.23.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Option Activities

The following table summarizes stock option activities for the nine months ended September 30, 2023:

    

    

    

Weighted Average

Remaining

Weighted Average

Contractual Life (in

Stock Options

Exercise Price

years)

Outstanding at December 31, 2022

 

76,112

$

59.09

 

4.31

Outstanding at September 30, 2023

 

76,112

$

59.09

 

3.56

Options vested and exercisable at September 30, 2023

 

47,570

$

59.09

 

3.56

Schedule of Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 (in thousands):

For the three months ended September 30, 

For the nine months ended September 30, 

    

2023

    

2022

    

2023

    

2022

General and administrative

$

119

$

194

$

381

$

549

Research and development (1)

 

(19)

 

302

 

(1)

 

1,261

Total stock-based compensation expense

$

100

$

496

$

380

$

1,810

(1) The credit in research and development stock-based compensation expense reflects the reversal of expense related to Restricted Stock Unit forfeitures during the three and nine months ended September 30, 2023.

Summary of Warrant Activities

A summary of warrant activities for the nine months ended September 30, 2023, is presented below:

    

    

    

Weighted Average

Remaining

Weighted Average

Contractual Life (in

Warrants

Exercise Price

years)

Outstanding as of December 31, 2022

 

70,195

$

22.80

 

8.29

Exercised

 

(93)

 

 

Outstanding as of September 30, 2023

 

70,102

$

22.80

 

7.55

Restricted Stock Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedules of Restricted Stock and Restricted Stock Unit Activity

The following table summarizes restricted stock award activities for the nine months ended September 30, 2023:

    

    

Weighted Average

Grant Date Fair

Number of Shares

Value

Nonvested at December 31, 2022

 

34,016

$

22.20

Granted

 

36,230

 

6.90

Vested

(5,540)

46.20

Nonvested at September 30, 2023

 

64,706

$

11.59

Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedules of Restricted Stock and Restricted Stock Unit Activity

Certain employees and consultants have been awarded restricted stock units with time-based vesting. The following table summarizes restricted stock units’ activities for the nine months ended September 30, 2023:

    

    

Weighted Average

Grant Date Fair

Number of Units

Value

Nonvested at December 31, 2022

 

165,912

$

27.60

Granted

 

29,732

 

5.13

Forfeited

(46,172)

27.93

Vested

 

(43,372)

 

32.82

Nonvested at September 30, 2023

 

106,100

$

19.03